polidocanol and Lymphoma--Primary-Effusion

polidocanol has been researched along with Lymphoma--Primary-Effusion* in 1 studies

Other Studies

1 other study(ies) available for polidocanol and Lymphoma--Primary-Effusion

ArticleYear
Highly selective fusion and accumulation of hybrid liposomes into primary effusion lymphoma cells along with induction of apoptosis.
    Biochemical and biophysical research communications, 2010, Mar-12, Volume: 393, Issue:3

    Primary effusion lymphoma (PEL) is an aggressive neoplasm caused by human herpes virus-8 infection, and is generally resistant to chemotherapy. Hybrid liposomes, composed of dimyristoylphosphatidylcholine (DMPC) and polyoxyethylene (21) dodecyl ether (C12(EO)21) (HL-21), were rapidly accumulated in the membrane of PEL cells. HL-21 also increased membrane fluidity of PEL cells, and induced caspase-3 activation along with cell death. These results suggest that HL-21 should be an effective and attractive regent for PEL treatment.

    Topics: Apoptosis; Cell Line, Tumor; Cell Membrane; Dimyristoylphosphatidylcholine; Humans; Liposomes; Lymphoma, Primary Effusion; Membrane Fluidity; Membrane Fusion; Polidocanol; Polyethylene Glycols

2010